Sanyou Raises $15M for AI Drug Discovery

Sanyou Biopharmaceuticals, a Shanghai-based biopharmaceutical company, raised nearly $15M in Series C financing from Zero2IPO Industry Investment on 09/11/2026. The total funding reaches nearly $45M to accelerate its AI-driven drug discovery system involving platforms like AI-STAL and SAI-DA, supporting its evolution toward building pipeline-driven capabilities for drug innovation.